NHS England announced today to have closed a deal with Novartis to grant access to Kymriah for patients up to 25 years old with B cell acute lymphoblastic leukaemia (ALL). Great news for English patients and hopefully NHS decision opens the way to similar decisions in other European countries. Here below NHS England press release:

NHS press release

Previous PostNext Post